Baue A E
Department of Surgery, St Louis University Health Sciences Center, Mo, USA.
Arch Surg. 1997 Jul;132(7):703-7. doi: 10.1001/archsurg.1997.01430310017002.
The concept of multiple organ failure and related abnormalities was first developed in the 1970s. Multiple organ failure became evident when the support systems in intensive care units were able to keep patients alive long enough for multiple organ problems to develop in them. The high mortality of patients with multiple organ failure provided a focus for the problems that ultimately led to death for many patients in the intensive care unit. The frequency of infection, sepsis, or inflammation in producing multiple organ failure led to clinical trials of so-called magic bullets for the treatment of patients with sepsis. These trials have had either limited success or negative results, despite considerable evidence for efficacy or protection by such agents in experimental animals and in studies of normal human volunteers. I believe a major reason for these negative results has been the use of general entry criteria for the trials rather than the treatment of specific diseases or injuries.
多器官功能衰竭及相关异常的概念最早是在20世纪70年代提出的。当重症监护病房的支持系统能够让患者存活足够长的时间,使多个器官出现问题时,多器官功能衰竭就变得明显了。多器官功能衰竭患者的高死亡率成为了许多重症监护病房患者最终死亡问题的焦点。感染、脓毒症或炎症在引发多器官功能衰竭方面的高发生率,促使人们开展了针对脓毒症患者的所谓神奇药物的临床试验。尽管有大量证据表明这些药物在实验动物和正常人类志愿者研究中具有疗效或保护作用,但这些试验要么取得了有限的成功,要么得到了负面结果。我认为这些负面结果的一个主要原因是试验采用了通用的入选标准,而不是针对特定疾病或损伤进行治疗。